Neogen Corp boosts revenues with resilient food safety growth amid supply chain challenges

Neogen Corp reports a steady rise in fiscal 2026 revenues driven by strong food safety demand and strategic expansions, despite currency pressures and supply chain disruptions.

Neogen Corp ended fiscal 2026 with a firmer top line, reporting fourth-quarter revenue of $245 million, up 7% from a year earlier, and full-year revenue of $950 million, a 6% rise, according to its latest earnings-call summary. Management said adjusted EBITDA reached $52 million in the quarter and $198 million for the year, helped by tighter cost control, a better product mix and operational efficiencies.

Food safety remained the main engine of growth. That division generated $155 million in the quarter, up 8%, on stronger demand for rapid pathogen detection kits and toxin-testing products. Animal safety revenue increased 5% to $90 million, supported by veterinary instruments and biosecurity equipment, particularly in livestock and poultry.

The company also said it gained ground in genomics through new launches and partnerships, while cash generation continued to support research spending and acquisition plans. It expects a further 50 to 100 basis points of gross-margin improvement in fiscal 2027, to 48% to 49%.

Offsetting those gains were currency pressure, supply-chain disruption in raw materials, softer diagnostic demand and higher interest costs. Neogen said it is widening its supplier base, increasing inventory buffers and nearshoring selected inputs, while targeting molecular diagnostics, Asia-Pacific expansion and bolt-on deals in animal health.